News & Updates

Serum concentrations of saturated fatty acids (SFAs) appear to predict the development of mild cognitive impairment (MCI) in middle-aged and older adults, reports a study.

Early initiation of blood pressure (BP)-lowering therapy is linked to a heightened risk of functional dependency or death among patients with single subcortical infarction (SSI) and coexisting parent artery disease (PAD) stenosis, as shown in a study.

In the treatment of patients with aneurysmal subarachnoid haemorrhage (aSAH), placing nicardipine release implants during microsurgical aneurysm repair appears to reduce the incidence of moderate to severe angiographic vasospasm and improve clinical outcomes, according to data from a phase 2b study.

Treatment with the orexin receptor antagonist suvorexant does not appear to significantly reduce the incidence of delirium in hospitalized older adults when compared with placebo, according to data from a phase III study.

New drug applications approved by US FDA as of 1-15 August 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.